Norcodeine

Source: Wikipedia, the free encyclopedia.
Norcodeine
Clinical data
Dependence
liability
High
ATC code
  • none
Legal status
Legal status
Identifiers
  • 3-Methoxy-6α-hydroxy-4,5α-epoxy-7,8-didehydromorphinan
JSmol)
  • COC1=C2C3=C(C[C@@H]4[C@H]5[C@]3(CCN4)[C@@H](O2)[C@H](C=C5)O)C=C1
  • InChI=1S/C17H19NO3/c1-20-13-5-2-9-8-11-10-3-4-12(19)16-17(10,6-7-18-11)14(9)15(13)21-16/h2-5,10-12,16,18-19H,6-8H2,1H3/t10-,11+,12-,16-,17-/m0/s1 ☒N
  • Key:HKOIXWVRNLGFOR-KOFBORESSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Norcodeine is an opiate analogue that is the N-demethylated derivative of codeine. It has relatively little opioid activity in its own right,[2] but is formed as a metabolite of codeine following ingestion.[3]

Norcodeine is a Schedule I Narcotic controlled substance in the US with the ACSCN of 9309 and zero annual manufacturing quota. The salts in use are the acetate (free base conversion ratio 0.826), hydroiodide (0.662), hydrochloride (0.759), nitrate (0.819), platinichloride (0.582), and sulphate (0.744).[4]

See also

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-03.
  2. PMID 13824628
    .
  3. .
  4. ^ "Quotas - 2014". DEA Diversion Control Division.